Laboratory results
| Baseline visit | Follow-up visit | P value | |
| High-sensitivity troponin T (pg/mL) | 3.9±1.3 | 3.9±1.1 | 0.99 |
| NT-proBNP (ng/L) | 68±44 | 71±48 | 0.66 |
| GOT (U/L) | 21±4 | 29±15 | 0.03 |
| GPT (U/L) | 22±9 | 30±36 | 0.39 |
| Bilirubin (mg/dL) | 0.8±0.4 | 0.8±0.2 | 0.31 |
| Gamma-GT (U/L) | 23±14 | 31±39 | 0.42 |
| Creatinine (mg(dL) | 0.9±0.1 | 0.8±0.1 | 0.02 |
| GFR (mL/min) | 96±20 | 96±17 | 0.90 |
| Cholesterol (mg/dL) | 204±23 | 201±33 | 0.44 |
| HDL-cholesterol (mg/dL) | 61±15 | 57±18 | 0.08 |
| LDL-cholesterol (mg/dL) | 127±23 | 123±28 | 0.26 |
| Haemoglobin A1c (%) | 5.5±0.2 | 5.3±0.2 | 0.76 |
| CRP (mg/L) | 2.5±1.4 | 2.2±0.8 | 0.63 |
| Haemoglobin (g(dL) | 14.2±1.2 | 14.3±1.3 | 0.45 |
| Haematocrit (%) | 42±3 | 41±3 | <0.001 |
| TSH (mU/L) | 1.4±0.8 | 1.0±0.4 | 0.04 |
| Uric acid (mg/dL) | 5±1 | 5±1 | 0.28 |
| Sodium (mmol/L) | 141±2 | 141±2 | 0.76 |
| Potassium (mmol/L) | 4.2±0.3 | 4.3±0.2 | 0.57 |
Continuous data were expressed as mean±SD.
CRP, C reactive protein; GFR, glomerular filtration rate; GOT, glutamic oxaloacetic transaminase; GPT, glutamic pyruvic transaminase; Gamma-GT, Gamma-Glutamyltranferase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NT-proBNP, N terminal pro-brain natriuretic peptide; TSH, thyroid-stimulating hormone.